SESSION I: Introduction and Keynote Address by Philip Gattone, CEO and President, Epilepsy Foundation.
SESSION II: What was better in 2013 than 2012--Progress in Epilepsy Therapy, moderated by Jacqueline French, MD, Professor of Neurology, New York University
The session includes the following presentations:
. FDA and epilepsy trials: Past, Present and Future
. Why Industry Should Keep Investing in Epilepsy
. The NINDS ASP: Yesterday, Today and Tomorrow
. Epilepsy Therapies: Accomplishments and Challenges
